NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

傳染病檢查的全球市場:各產品和服務,技術,疾病,終端用戶,地區,競爭預測和機會(2026年)

Global Infectious Disease Testing Market, By Product & Service, By Technology, By Disease, By End User, By Region, Competition Forecast & Opportunities, 2026

出版商 TechSci Research 商品編碼 1008723
出版日期 內容資訊 英文 113 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

傳染病檢查的全球市場:各產品和服務,技術,疾病,終端用戶,地區,競爭預測和機會(2026年) Global Infectious Disease Testing Market, By Product & Service, By Technology, By Disease, By End User, By Region, Competition Forecast & Opportunities, 2026
出版日期: 2021年06月01日內容資訊: 英文 113 Pages
簡介

全球傳染病檢查市場,2020年是167億5,339萬美金。

預計該市場,至2026年期間以約8.27%的年複合成長率成長,達到277億1,209萬美元。該市場,由於全球感染疾病患者增加所推動。政府的醫療保健基本設備的投資,預計在預測期間內促進市場成長,以及,醫療保健領域的研究開發活動增加,預計推動市場成長。

本報告提供全球傳染病檢查市場的相關調查,市場規模和預測,佔有率,COVID-19的影響,成長要素和課題,各產品和服務、技術、疾病、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球傳染病檢查市場的影響

第4章 摘要整理

第5章 客戶的迴響

  • 品牌認知度(支援)
  • 顧客滿意度分析
  • 未滿足需求/課題

第6章 全球傳染病檢查市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品及服務(化驗,套件,及試劑,設備,服務及軟體)
    • 各技術(分子診斷,免疫測量,微生物學,其他)
    • 各疾病(肝炎,人類乳突病毒(HPV),人類免疫力缺乏病毒(HIV),結核(TB),院內感染(HAI),其他)
    • 各終端用戶(醫院/臨床檢驗實驗室,診斷 索引實驗室,學術/研究機關,其他)
    • 各企業(2020)
    • 各地區
  • 產品市場地圖

第7章 北美的傳染病檢查市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品及服務
    • 各技術
    • 各疾病
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國
    • 加拿大
    • 墨西哥

第8章 歐洲的傳染病檢查市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品及服務
    • 各技術
    • 各疾病
    • 各終端用戶
    • 各國
  • 歐洲:各國分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第9章 亞太地區的傳染病檢查市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品及服務
    • 各技術
    • 各疾病
    • 各終端用戶
    • 各國
  • 亞太地區:各國分析
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲

第10章 南美的傳染病檢查市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品及服務
    • 各技術
    • 各疾病
    • 各終端用戶
    • 各國
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章 中東及非洲的傳染病檢查市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品及服務
    • 各技術
    • 各疾病
    • 各終端用戶
    • 各國
  • 中東、非洲:各國分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第12章 市場動態

  • 成長要素
  • 課題

第13章 市場趨勢

第14章 競爭情形

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Johnson and Johnson
  • F. Hoffmann-La Roche Ltd
  • Cepheid Inc.
  • Qiagen N.V.
  • OraSure Technologies, Inc.

第15章 策略性建議

第16章 關於本公司&免責聲明

目錄
Product Code: 4695

Global infectious disease testing market was valued at USD16753.39 million in 2020 and is anticipated to reach USD27712.09 million in 2026 by registering a growing CAGR of around 8.27%. The global infectious disease testing market is driven by rising population having infectious diseases across the globe. Moreover, investments in healthcare infrastructure by governments across the globe is expected to fuel the growth of market during the forecast period. Also, increase in research and developmental activities in the healthcare sector is further expected to bolster the growth of market over the next few years.

The global infectious disease testing market is segmented based on product and service, technology, disease, end user, company, and region. Based on product and service, the market can be categorized into assays, kits, & reagents; instruments; services & software. Out of which, the assays, kits, & reagents segment dominated the market in terms of largest market share in 2020 and is expected to maintain its leading position in the market during the forecast period as well. This can be ascribed to ease of accessibility coupled with rising number of IDD tests that are being conducted. In addition to this, the volume of IDD tests is growing primarily because of increasing geriatric population along with rising incidence of infectious diseases. Moreover, ongoing development of newer, faster, and more reliable products is further anticipated to boost the growth of segment over the coming years. Along with that, the reagents are available in variety, which is further aiding the market growth.

Major players operating in the global infectious disease testing market include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., Meridian Bioscience Inc., Quidel Corporation, Siemens AG, Thermo Fisher Scientific Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, Cepheid Inc., Qiagen N.V., OraSure Technologies, Inc. and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of global infectious disease testing market from 2016 to 2020.
  • To estimate and forecast the market size of global infectious disease testing market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global infectious disease testing market based on product and service, technology, disease, end user, company and regional distribution.
  • To identify dominant region or segment in the global infectious disease testing market.
  • To identify drivers and challenges for global infectious disease testing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global infectious disease testing market.
  • To conduct pricing analysis for global infectious disease testing market.
  • To identify and analyze the profile of leading players operating in global infectious disease testing market.
  • To identify key sustainable strategies adopted by market players in global infectious disease testing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global infectious disease testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Infectious disease testing hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to infectious disease testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global infectious disease testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Infectious Disease Testing Market, By Product and Service:

Assays, Kits, & Reagents

Instruments

Services & Software

  • Global Infectious Disease Testing Market, By Technology:

Molecular Diagnostics

Immunoassay

Microbiology

Others

  • Global Infectious Disease Testing Market, By Disease:

Hepatitis

Human Papillomavirus (HPV)

Human Immunodeficiency Virus (HIV)

Tuberculosis (TB)

Hospital-Acquired Infections (HAIs)

Others

  • Global Infectious Disease Testing Market, By End User:

Hospital/Clinical Laboratories

Diagnostic Reference Laboratories

Academic/Research Institutes

Others

  • Global Infectious Disease Testing Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global infectious disease testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Infectious Disease Testing Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness (Aided/Unaided)
  • 5.2. Customer Satisfaction Analysis
  • 5.3. Unmet Needs/Challenges

6. Global Infectious Disease Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software)
    • 6.2.2. By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Others)
    • 6.2.3. By Disease (Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections (HAIs), Others)
    • 6.2.4. By End User (Hospital/Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other)
    • 6.2.5. By Company (2020)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. North America Infectious Disease Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Technology
    • 7.2.3. By Disease
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Infectious Disease Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Disease
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Infectious Disease Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Disease
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Infectious Disease Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Disease
        • 7.3.3.2.4. By End User

8. Europe Infectious Disease Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Technology
    • 8.2.3. By Disease
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Infectious Disease Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Disease
        • 8.3.1.2.4. By End User
    • 8.3.2. United Kingdom Infectious Disease Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Disease
        • 8.3.2.2.4. By End User
    • 8.3.3. France Infectious Disease Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Disease
        • 8.3.3.2.4. By End Use
    • 8.3.4. Italy Infectious Disease Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Disease
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Infectious Disease Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Disease
        • 8.3.5.2.4. By End User

9. Asia-Pacific Infectious Disease Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Technology
    • 9.2.3. By Disease
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Infectious Disease Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Disease
        • 9.3.1.2.4. By End User
    • 9.3.2. Japan Infectious Disease Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Disease
        • 9.3.2.2.4. By End User
    • 9.3.3. India Infectious Disease Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Disease
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Infectious Disease Testing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product and Service
        • 9.3.4.2.2. By Technology
        • 9.3.4.2.3. By Disease
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Infectious Disease Testing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product and Service
        • 9.3.5.2.2. By Technology
        • 9.3.5.2.3. By Disease
        • 9.3.5.2.4. By End User

10. South America Infectious Disease Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Technology
    • 10.2.3. By Disease
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Infectious Disease Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Disease
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Infectious Disease Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Disease
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Infectious Disease Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Disease
        • 10.3.3.2.4. By End Use

11. Middle East and Africa Infectious Disease Testing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product and Service
    • 11.2.2. By Technology
    • 11.2.3. By Disease
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Infectious Disease Testing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product and Service
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Disease
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Infectious Disease Testing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product and Service
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Disease
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Infectious Disease Testing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product and Service
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Disease
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Abbott Laboratories
  • 14.2. Becton, Dickinson and Company
  • 14.3. bioMerieux SA
  • 14.4. Bio-Rad Laboratories Inc.
  • 14.5. Danaher Corporation
  • 14.6. DiaSorin S.p.A.
  • 14.7. Meridian Bioscience Inc.
  • 14.8. Quidel Corporation
  • 14.9. Siemens AG
  • 14.10. Thermo Fisher Scientific Inc.
  • 14.11. Johnson and Johnson
  • 14.12. F. Hoffmann-La Roche Ltd
  • 14.13. Cepheid Inc.
  • 14.14. Qiagen N.V.
  • 14.15. OraSure Technologies, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Global Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 3: Global Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 4: Global Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 5: Global Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 6: Global Infectious Disease Testing Market Share, By Company, 2020
  • Figure 7: Global Infectious Disease Testing Market Share, By Region, By Value, 2016-2026F
  • Figure 8: Global Infectious Disease Testing Product Market Map, By Value, 2016-2026F
  • Figure 9: North America Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 10: North America Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 11: North America Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 12: North America Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 13: North America Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 14: North America Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
  • Figure 15: United States Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 16: United States Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 17: United States Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 18: United States Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 19: United States Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 20: Canada Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 21: Canada Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 22: Canada Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 23: Canada Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 24: Canada Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 25: Mexico Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 26: Mexico Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 27: Mexico Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 28: Mexico Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 29: Mexico Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 30: Europe Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 31: Europe Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 32: Europe Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 33: Europe Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 34: Europe Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 35: Europe Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
  • Figure 36: Germany Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 37: Germany Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 38: Germany Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 39: Germany Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 40: Germany Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 41: United Kingdom Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 42: United Kingdom Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 43: United Kingdom Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 44: United Kingdom Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 45: United Kingdom Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 46: France Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 47: France Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 48: France Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 49: France Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 50: France Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 51: Italy Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 52: Italy Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 53: Italy Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 54: Italy Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 55: Italy Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 56: Spain Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 57: Spain Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 58: Spain Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 59: Spain Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 60: Spain Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 61: Asia Pacific Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 62: Asia Pacific Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 63: Asia Pacific Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 64: Asia Pacific Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 65: Asia Pacific Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 66: Asia Pacific Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
  • Figure 67: China Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 68: China Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 69: China Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 70: China Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 71: China Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 72: Japan Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 73: Japan Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 74: Japan Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 75: Japan Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 76: Japan Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 77: India Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 78: India Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 79: India Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 80: India Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 81: India Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 82: South Korea Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 83: South Korea Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 84: South Korea Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 85: South Korea Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 86: South Korea Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 87: Australia Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 88: Australia Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 89: Australia Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 90: Australia Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 91: Australia Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 92: South America Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 93: South America Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 94: South America Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 95: South America Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 96: South America Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
  • Figure 97: Brazil Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 98: Brazil Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 99: Brazil Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 100: Brazil Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 101: Brazil Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 102: Argentina Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 103: Argentina Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 104: Argentina Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 105: Argentina Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 106: Argentina Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 107: Colombia Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 108: Colombia Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 109: Colombia Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 110: Colombia Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 111: Colombia Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 112: Middle East & Africa Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 113: Middle East & Africa Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 114: Middle East & Africa Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 115: Middle East & Africa Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 116: Middle East & Africa Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 117: Middle East & Africa Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
  • Figure 118: South Africa Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 119: South Africa Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 120: South Africa Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 121: South Africa Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 122: South Africa Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 123: Saudi Arabia Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 124: Saudi Arabia Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 125: Saudi Arabia Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 126: Saudi Arabia Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 127: Saudi Arabia Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
  • Figure 128: UAE Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
  • Figure 129: UAE Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
  • Figure 130: UAE Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
  • Figure 131: UAE Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
  • Figure 132: UAE Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F